Skip to content

US · EUDAW · MEDICAL - HEALTHCARE INFORMATION SERVICES

EUDA Health Holdings Limited (EUDAW) intrinsic value and stock valuation

$0.02as of 2026-11-21 · Mkt cap 1.06M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

EUDA Health Holdings Limited DCF and intrinsic value

InvestorsCraft values EUDAW with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from EUDAW’s statements →

EUDA Health Holdings Limited Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Singapore, CE 415979 eudahealth.com

How the business is doing

Fiscal 2020–2025, USD

Revenue
$6.82M-5.1% 5y CAGRd
20202025
Net income
-$-2.77M
20202025
Free cash flow
-$-2.53M
20202025
Total equity
-$-4.27M
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2020–2025, USD
20252024202320222021
Revenue$6.82M$4.01M$3.71M$3.76M$4.56M
Operating income-$-2.44M-$-17.34M-$-3.96M-$-5.72M-$-560K
Net income-$-2.77M-$-15.36M-$-10.04M-$-24.88M$860K
EPSd-$-1.49M-$-9.48M-$-8.73M-$-41.47M$1.87M
Operating cash flow-$-2.43M-$-2.03M-$-2.92M-$-1.53M$440K
Capital expenditure-$-100K-$-120K-$0.00-$-20K-$0.00
Free cash flow-$-2.53M-$-2.15M-$-2.92M-$-1.54M$440K
Total assets$1.72M$1.73M$1.31M$25.6M$8M
Total debt$2.4M$1.27M$3.37M$3.63M$460K
Net debt$2.06M$1.03M$3.19M$3.57M$270K
Total equity-$-4.27M-$-2.57M-$-7.48M-$-3.51M$600K
Cash and short-term investments$350K$240K$190K$60K$190K
Income statement
20252024202320222021
Revenue$6.82M$4.01M$3.71M$3.76M$4.56M
Cost of revenue$3.83M$3.25M$2.86M$2.89M$3.31M
Gross profit$2.99M$760K$840K$870K$1.25M
Research and development expenses$0.00$0.00$0.00$20K$130K
Selling, general and administrative expenses$5.43M$3.34M$4.8M$6.75M$1.81M
Other expenses$0.00$14.8M$0.00$6.32M-$-130K
Operating expenses$5.43M$18.1M$4.8M$13.1M$1.81M
Cost and expenses$9.26M$21.4M$7.67M$16M$5.12M
Interest income$0.00$0.00$0.00$0.00$1.92M
Interest expense$230K$40K$20K$90K$130K
Depreciation and amortization$410K$170K$110K$260K$260K
Ebitda-$-2.09M-$-17.42M-$-8.3M-$-24.56M$1.34M
Operating income-$-2.44M-$-17.34M-$-3.96M-$-5.72M-$-560K
Total other income/expenses, net-$-290K-$-310K-$-4.47M-$-19.21M$2.23M
Income before tax-$-2.73M-$-17.64M-$-8.43M-$-24.93M$1.67M
Income tax expense$40K-$0.00$0.00-$-20K$50K
Net income-$-2.77M-$-15.36M-$-10.04M-$-24.88M$860K
Weighted average shares outstanding$1.86M$1.62M$1.36M$600K$460K
Weighted average diluted shares outstanding$1.86M$1.62M$1.15M$600K$460K
Balance sheet
20252024202320222021
Cash and short-term investments$350K$240K$190K$60K$190K
Net receivables$330K$170K$240K$190K$4.09M
Inventory$0.00$130K$0.00$650K$0.00
Total current assets$1.04M$760K$720K$25M$4.35M
Property, plant and equipment, net$330K$320K$210K$120K$160K
Goodwill and intangible assets$160K$340K$0.00$0.00$1.28M
Long-term investments$0.00$0.00$0.00$0.00$2.2M
Total non-current assets$680K$970K$590K$600K$3.65M
Total assets$1.72M$1.73M$1.31M$25.6M$8M
Accounts payable$10K$30K$0.00$1.46M$2.82M
Short-term debt$2.33M$1.22M$3.3M$3.62M$430K
Deferred revenue$520K$480K$0.00-$-3.69M$0.00
Total current liabilities$5.84M$4.14M$8.72M$29.1M$7.32M
Long-term debt$70K$50K$80K$20K$30K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$150K$160K$80K$20K$80K
Capital lease obligations$200K$230K$200K$60K$110K
Total liabilities$5.98M$4.3M$8.79M$29.1M$7.4M
Common stock$48.8M$47.8M$27.4M$21.3M$330K
Retained earnings-$-52.87M-$-50.1M-$-34.74M-$-24.7M$180K
Accumulated other comprehensive income (loss)-$-210K-$-260K-$-190K-$-130K$10K
Total equity-$-4.27M-$-2.57M-$-7.48M-$-3.51M$600K
Total investments$0.00$0.00$0.00$0.00$2.2M
Total debt$2.4M$1.27M$3.37M$3.63M$460K
Net debt$2.06M$1.03M$3.19M$3.57M$270K
Cash flow statement
20252024202320222021
Net income-$-2.77M-$-17.6M-$-8.44M-$-24.95M$900K
Depreciation and amortization$410K$170K$120K$170K$260K
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-230K$190K$530K$1.12M$1.18M
Accounts receivable-$-170K$80K-$-30K-$-170K-$-260K
Inventory$50K-$-130K$0.00$3.69M$0.00
Accounts payable-$-10K$20K$0.00-$-1.13M$1.38M
Net cash provided by operating activities-$-2.43M-$-2.03M-$-2.92M-$-1.53M$440K
Investments in property, plant and equipment-$-80K-$-120K-$0.00-$-20K-$0.00
Acquisitions, net$0.00$20K$0.00-$0.00-$-350K
Net cash used for investing activities-$-100K-$-150K$0.00-$-270K-$-360K
Common stock issued$100K$50K$790K$1.1M$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$2.55M$2.32M$2.35M$2.49M-$-170K
Net change in cash$110K$40K-$-590K$590K-$-60K
Cash at end of period$350K$240K$200K$780K$190K
Operating cash flow-$-2.43M-$-2.03M-$-2.92M-$-1.53M$440K
Capital expenditure-$-100K-$-120K-$0.00-$-20K-$0.00
Free cash flow-$-2.53M-$-2.15M-$-2.92M-$-1.54M$440K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About EUDA Health Holdings Limited

        EUDA Health Limited, established in Singapore in 2019, offers a digital healthcare platform that facilitates online consultations for minor health concerns. The firm functions as a subsidiary of Watermark Developments Limited.

        CEO
        Alfred Lim
        Employees
        123
        Beta
        0.64

        Explore

        Frequently asked questions

        What is the intrinsic value of EUDA Health Holdings Limited (EUDAW)?

        InvestorsCraft does not currently publish an intrinsic value for EUDAW. How the IC value is calculated.

        Is EUDAW undervalued?

        InvestorsCraft does not publish an undervaluation signal for EUDAW at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.